Sudapyridine

DRUG2 trials

Sponsors

Shanghai Jiatan Pharmatech Co., Ltd

Conditions

Rifampicin-Resistant Pulmonary Tuberculosis PatientsRifampin-Resistant Pulmonary TuberculosisTuberculosis, Multidrug-Resistant (MDR-TB)

Phase 1

Drug-Drug Interaction and Food Effect of Sudapyridine(WX-081) With Itraconazole and Rifampin in Healthy Chinese Adults

Not yet recruitingNCT06701136

Shanghai Jiatan Pharmatech Co., LtdRifampicin-Resistant Pulmonary Tuberculosis Patients

Start: 2025-05-12End: 2026-02-12Target: 16Updated: 2025-02-12

Phase 3

A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients

RecruitingNCT05824871

Shanghai Jiatan Pharmatech Co., LtdRifampin-Resistant Pulmonary Tuberculosis, Tuberculosis, Multidrug-Resistant (MDR-TB)

Start: 2022-09-02End: 2026-10-22Target: 450Updated: 2025-06-29